A. Rini

发表

Synergistic effects of testosterone and growth hormone on protein metabolism and body composition in prepubertal boys.

N. Mauras, S. Welch, A. Rini, 2003, Metabolism: clinical and experimental.

Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism.

N. Mauras, J. Guevara-Aguirre, A. Rini, 2000, The Journal of clinical endocrinology and metabolism.

Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism.

N. Mauras, A. Yergey, K. Helgeson, 2000, The Journal of clinical endocrinology and metabolism.

Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Testosterone Deficiency in Young Men: Marked Alterations in Whole Body Protein Kinetics, Strength, and Adiposity*

N. Mauras, K. Helgeson, R. Urban, 2022 .

Ovarian hyperandrogenism is associated with insulin resistance to both peripheral carbohydrate and whole-body protein metabolism in postpubertal young females: a metabolic study.

N. Mauras, M. Haymond, S. Welch, 1998, The Journal of clinical endocrinology and metabolism.

Phenylbutyrate-induced glutamine depletion in humans: effect on leucine metabolism.

M. Haymond, S. Welch, A. Rini, 1998, American journal of physiology. Endocrinology and metabolism.

An Open Label 12-Month Pilot Trial on the Effects of the Aromatase Inhibitor Anastrozole in Growth Hormone (GH)-Treated GH Deficient Adolescent Boys

N. Mauras, S. Welch, A. Rini, 2004, Journal of pediatric endocrinology & metabolism : JPEM.

Ovarian hyperandrogenism is associated with insulin resistance to both peripheral carbohydrate and whole-body protein metabolism in postpubertal young females: a metabolic study.

N. Mauras, M. Haymond, S. Welch, 1998, The Journal of clinical endocrinology and metabolism.

Pharmacokinetics and dose finding of a potent aromatase inhibitor, aromasin (exemestane), in young males.

N. Mauras, A. Rini, J. Lima, 2003, The Journal of clinical endocrinology and metabolism.

Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study.

D. Milov, N. Mauras, S. Abrams, 2002, Metabolism: clinical and experimental.

Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism.

N. Mauras, A. Yergey, K. Helgeson, 2000, The Journal of clinical endocrinology and metabolism.